Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
Тип публикации: Journal Article
Дата публикации: 1993-07-01
SCImago Q1
WOS Q1
БС1
SJR: 1.353
CiteScore: 7.8
Impact factor: 4.3
ISSN: 01663542, 18729096
PubMed ID:
7692815
Pharmacology
Virology
Краткое описание
Thiazolobenzimidazole (NSC 625487) was a highly potent inhibitor of human immunodeficiency virus-induced cell killing and viral replication in a variety of human cell lines, as well as fresh human peripheral blood lymphocytes and macrophages. The compound was active against a panel of biologically diverse laboratory and clinical strains of HIV-1, including the AZT-resistant strain G910-6. However, the agent was inactive against HIV-2 and a pyridinone-resistant strain (A17) of HIV-1, a strain which is cross-resistant to several structurally diverse members of a common pharmacologic class of nonnucleoside reverse transcriptase inhibitors. The compound selectively inhibited HIV-1 reverse transcriptase but not HIV-2 reverse transcriptase. Combinations of thiazolobenzimidazole with either AZT or ddI synergistically inhibited HIV-1 induced cell killing in vitro. Thiazolobenzimidazole also inhibited the replication of the Rauscher murine leukemia retrovirus. Thus, thiazolobenzimidazole is a new active anti-HIV-1 chemotype and may represent a subclass of nonnucleoside reverse transcriptase inhibitors with an enhanced range of anti-retroviral activity.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
2
4
6
8
10
|
|
|
Antiviral Chemistry and Chemotherapy
10 публикаций, 14.08%
|
|
|
Bioorganic and Medicinal Chemistry
9 публикаций, 12.68%
|
|
|
Journal of Medicinal Chemistry
7 публикаций, 9.86%
|
|
|
Antiviral Research
5 публикаций, 7.04%
|
|
|
AIDS Research and Human Retroviruses
3 публикации, 4.23%
|
|
|
Bioorganic and Medicinal Chemistry Letters
2 публикации, 2.82%
|
|
|
Journal of Molecular Structure
2 публикации, 2.82%
|
|
|
Organic and Biomolecular Chemistry
2 публикации, 2.82%
|
|
|
Expert Opinion on Therapeutic Patents
2 публикации, 2.82%
|
|
|
Synlett
2 публикации, 2.82%
|
|
|
Journal of Virological Methods
1 публикация, 1.41%
|
|
|
Journal of Inorganic Biochemistry
1 публикация, 1.41%
|
|
|
European Journal of Cancer
1 публикация, 1.41%
|
|
|
Il Farmaco
1 публикация, 1.41%
|
|
|
Protein Expression and Purification
1 публикация, 1.41%
|
|
|
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
1 публикация, 1.41%
|
|
|
Medicinal Chemistry Research
1 публикация, 1.41%
|
|
|
Drug Information Journal
1 публикация, 1.41%
|
|
|
Pharmaceutical Chemistry Journal
1 публикация, 1.41%
|
|
|
Archives of Pharmacal Research
1 публикация, 1.41%
|
|
|
Russian Chemical Reviews
1 публикация, 1.41%
|
|
|
Tetrahedron
1 публикация, 1.41%
|
|
|
Biochemical Pharmacology
1 публикация, 1.41%
|
|
|
Journal of Biological Chemistry
1 публикация, 1.41%
|
|
|
Virology
1 публикация, 1.41%
|
|
|
FEBS Letters
1 публикация, 1.41%
|
|
|
Annals of the New York Academy of Sciences
1 публикация, 1.41%
|
|
|
Reviews in Medical Virology
1 публикация, 1.41%
|
|
|
Journal of Heterocyclic Chemistry
1 публикация, 1.41%
|
|
|
Medicinal Research Reviews
1 публикация, 1.41%
|
|
|
2
4
6
8
10
|
Издатели
|
5
10
15
20
25
30
|
|
|
Elsevier
27 публикаций, 38.03%
|
|
|
SAGE
10 публикаций, 14.08%
|
|
|
American Chemical Society (ACS)
7 публикаций, 9.86%
|
|
|
Wiley
5 публикаций, 7.04%
|
|
|
Taylor & Francis
5 публикаций, 7.04%
|
|
|
Mary Ann Liebert
3 публикации, 4.23%
|
|
|
Springer Nature
3 публикации, 4.23%
|
|
|
Royal Society of Chemistry (RSC)
2 публикации, 2.82%
|
|
|
Georg Thieme Verlag KG
2 публикации, 2.82%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.41%
|
|
|
Pharmaceutical Society of Korea
1 публикация, 1.41%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 1.41%
|
|
|
American Society for Biochemistry and Molecular Biology
1 публикация, 1.41%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 1.41%
|
|
|
American Society for Microbiology
1 публикация, 1.41%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 1.41%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
71
Всего цитирований:
71
Цитирований c 2025:
0
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Buckheit R. W. et al. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. // Antiviral Research. 1993. Vol. 21. No. 3. pp. 247-265.
ГОСТ со всеми авторами (до 50)
Скопировать
Buckheit R. W., Hollingshead M. G., GERMANY-DECKER J., White E. L., McMahon J. B., ALLEN L. B., Ross L., DECKER W. D., Westbrook L., Shannon W. M., Weislow O., BADER J. P., Boyd M. R. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. // Antiviral Research. 1993. Vol. 21. No. 3. pp. 247-265.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/0166-3542(93)90031-D
UR - https://doi.org/10.1016/0166-3542(93)90031-D
TI - Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
T2 - Antiviral Research
AU - Buckheit, Robert W
AU - Hollingshead, Melinda G.
AU - GERMANY-DECKER, JULIE
AU - White, E. Lucile
AU - McMahon, James B.
AU - ALLEN, LOIS B.
AU - Ross, Larry J.
AU - DECKER, WILLIAM D.
AU - Westbrook, Louise
AU - Shannon, William M.
AU - Weislow, Owen
AU - BADER, JOHN P.
AU - Boyd, Michael R
PY - 1993
DA - 1993/07/01
PB - Elsevier
SP - 247-265
IS - 3
VL - 21
PMID - 7692815
SN - 0166-3542
SN - 1872-9096
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{1993_Buckheit,
author = {Robert W Buckheit and Melinda G. Hollingshead and JULIE GERMANY-DECKER and E. Lucile White and James B. McMahon and LOIS B. ALLEN and Larry J. Ross and WILLIAM D. DECKER and Louise Westbrook and William M. Shannon and Owen Weislow and JOHN P. BADER and Michael R Boyd},
title = {Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.},
journal = {Antiviral Research},
year = {1993},
volume = {21},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016/0166-3542(93)90031-D},
number = {3},
pages = {247--265},
doi = {10.1016/0166-3542(93)90031-D}
}
Цитировать
MLA
Скопировать
Buckheit, Robert W., et al. “Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor..” Antiviral Research, vol. 21, no. 3, Jul. 1993, pp. 247-265. https://doi.org/10.1016/0166-3542(93)90031-D.
Ошибка в публикации?